As cold and flu season arrives, one of the most important challenges in healthcare is determining whether a respiratory infection is viral or bacterial. Accurate diagnosis not only guides effective treatment but also helps protect patients — and the community — from unnecessary antibiotic use and complications.
Why It Matters
- Treatment Accuracy
Viral infections, such as the common cold, flu, or RSV, typically do not require antibiotics. These medications are only effective against bacterial infections. Using antibiotics when they aren’t needed can lead to antibiotic resistance — making future infections harder to treat. - Symptom Duration and Care
Viral respiratory infections generally improve within 5–7 days, while bacterial infections may last longer and can worsen without targeted therapy. Understanding the cause allows healthcare providers to recommend the right course of action, whether that’s rest and fluids or prescription treatment. - Personalized Patient Care
By distinguishing between viral and bacterial infections, healthcare providers can better tailor care plans — offering specific symptom relief, follow-up guidance, and prevention strategies to support faster recovery and reduce complications. - Public Health Impact
Accurate diagnosis supports broader public health efforts, including infection control and vaccination initiatives, to limit the spread of respiratory illnesses throughout the community.
Advancing Diagnosis Through Research
New point-of-care testing devices are being developed to help clinicians diagnose respiratory infections more quickly and accurately. These innovations work for healthcare by helping providers in determining the nature of an infection during a patient visit by improving treatment outcomes and reducing unnecessary antibiotic use.
Hometown Research: Current Studies
Hometown Research is currently enrolling participants in studies designed to improve the speed and accuracy of respiratory infection diagnosis:
- Bacterial vs. Non-Bacterial Respiratory Infections
Enrollment requirements:
-
- Ages 2 through 11 years old
- Evaluates new testing methods to differentiate bacterial from viral infections in children.
- Pertussis (Whooping Cough) Testing Device Study
Enrollment requirements:
-
- Ages 2 years through adults (no upper age limit)
- Participants receive a confirmed diagnosis within 72 hours from a certified lab.
Study volunteers are compensated for their time and play an important role in advancing research that benefits patients and providers alike.
Join Us in Advancing Respiratory Health
At Hometown Research, our mission is to support innovation that improves patient care and strengthens community health. To learn more about our active studies or to see if you qualify, please contact our research team at https://myhometownuc.com/clinical-research/
Together, we’re building healthier futures — one study at a time.